A randomized, double blind, placebo controlled clinical study has been performed with Ellirose™. This study adds further evidence that Ellirose™ may help support a healthy urinary tract.
Allaert F.A. 2010, Lettre de l’infectiologue, Tome XXV, N°2: 56-60
This clinical study evaluated the recurrence of urinary infections among women who are particularly susceptible to reoccurring episodes. The results were evaluated after 3 and 6 months with a supplementation with Ellirose™.
Conclusion: The frequency of urinary infections reported reduced significantly with Ellirose™ compared to 3 months before the study started. After 6 months urinary infections were reduced by 89%. The reduction in frequency is all the more significant versus placebo at 6 months (p<0.01).
In the study, doctors also evaluated the benefit of the supplementation on the urinary wellbeing of women.
Conclusion: Doctors considered that the supplementation of Ellirose™ was significantly improving urinary women wellbeing in 68% of patients versus only 22% for the placebo.